At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer. Our goal is to bring the promise of cell therapy to as many eligible patients as possible who may benefit. Since 2009, Kite has been at the forefront of cancer immunotherapy. Today, we are proud to be the leader in engineered T cell therapy for hematologic malignancies, but we recognize that this is just the beginning. Patients are at the heart of our focus on the cure, which is why we are committed to pursuing cell therapy as a transformative treatment option for as many people with cancer as possible who may benefit. Cancer is personal to us. Unlike traditional pharmaceutical manufacturing, our therapies are not created on an assembly line. Cell therapy specialists at our manufacturing facilities reengineer a patient’s own immune cells to attack and fight their cancer cells — one patient at a time. That sense of connection to the people we serve motivates us daily at Kite. Our corporate headquarters are located in Santa Monica, California, and we have dedicated cell therapy manufacturing facilities in California, Maryland and the Netherlands. If you’re passionate about changing the future of cancer treatment, let’s talk. See our community guidelines: https://bit.ly/2DznMNw
Kite Pharma的外部链接
Kite Pharma转发了
At Gilead, patients are at the heart of everything we do – and we’re focused on developing and delivering innovative therapies across virology,?oncology?and inflammatory diseases. As we gather today for our annual Science Day, learn why our researchers are passionate about the work they do. #GileadLife
Nine years ago, Emily, a wife and mother of three young children, was given six months to live. She entered into a clinical trial for a treatment that was new at the time: CAR T-cell therapy. Recently, Emily shared her story in Newsweek’s My Turn column to help other families who are facing a cancer diagnosis.
On #WorldLeukemiaDay, we honor the strength and resilience of those affected by leukemia. Branden’s story is a powerful reminder of?the importance of having care partners and a support network. #WLD24
We’re proud to once again join The Leukemia & Lymphoma Society?for Light The Night as the National Presenting Sponsor of Celebration & Community. Join us this fall and help bring light to the darkness of cancer.?? ? #LightTheNight
At Kite and Gilead Sciences, we're dedicated to advancing research and expanding treatment options for people living with blood cancer. We’re proud to join our colleagues during #BloodCancerAwarenessMonth, and all year long, to raise awareness and stand with this resilient community.
We believe #celltherapy has the ability to change the way cancer is treated. Our sole focus is the research, development, manufacturing and commercialization of these innovative therapies for people in need of treatment options.???
At Kite, our sole focus is on the research,?development?and delivery of #CARTcell therapy because our goal is to bring these innovative treatments to as many eligible patients as possible.
Kite Pharma转发了
#GileadNews: Read the press release to learn more about our financial results from last quarter. https://gilead.inc/46GkIvL